PCSK9 Inhibitors

**Definition:** Agents that inhibit Proprotein Convertase Subtilisin/Kexin Type 9 (see PROPROTEIN CONVERTASE 9 (PCSK9)), an enzyme that plays an important role in the degradation of the LDL receptors. It favors LDL catabolism and reduces plasma LDL-cholesterol (LDL_C) level.

**Tree numbers:** - D27.505.519.186.071.202.685 - D27.505.519.389.745.800.506 - D27.505.954.557.500.202.685